Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

IMPORTANCE: Despite being the most common female sexual health complaint worldwide, current treatment options for hypoactive sexual desire disorder (HSDD) are limited in their safety and effectiveness. The hormone kisspeptin is a key endogenous activator of the reproductive hormonal axis with additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thurston, Layla, Hunjan, Tia, Ertl, Natalie, Wall, Matthew B., Mills, Edouard G., Suladze, Sofiya, Patel, Bjial, Alexander, Emma C., Muzi, Beatrice, Bassett, Paul A., Rabiner, Eugenii A., Bech, Paul, Goldmeier, David, Abbara, Ali, Comninos, Alexander N., Dhillo, Waljit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606846/
https://www.ncbi.nlm.nih.gov/pubmed/36287566
http://dx.doi.org/10.1001/jamanetworkopen.2022.36131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606846/
https://www.ncbi.nlm.nih.gov/pubmed/36287566
http://dx.doi.org/10.1001/jamanetworkopen.2022.36131

Ejemplares similares